The ruling makes clear that the FDA lacks the legal authority to regulate LDTs, and observers suggest it could also call into question its authority in other areas.
The blowback from this led in part to the FDA reorganizing its structure in 2024. In its announcement Tuesday, the FDA listed a set of actions it says will support nutritional adequacy and supply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback